<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03651323</url>
  </required_header>
  <id_info>
    <org_study_id>ISRCAR00144</org_study_id>
    <nct_id>NCT03651323</nct_id>
  </id_info>
  <brief_title>Latin America Registry on WatchmanTM Outcomes in Real Life</brief_title>
  <acronym>LATINAWERICA</acronym>
  <official_title>Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation: Latin America Registry on WatchmanTM Outcomes in Real Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Medico Docente la Trinidad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centro Medico Docente la Trinidad</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left atrial appendage (LAA) occlusion with WatchmanTM has emerged as viable alternative to
      anticoagulation therapy in randomized controlled trials. The device has FDA approved since
      2015 and the firsts Latin American cases were performed in 2012. However, there is no real
      world data from Latin American experience in terms of success and outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 450 subjects will be enrolled in the study. Up to 50 sites in Latin America
      will participate in the study.

      Primary analyses may include, but will not be limited to, the following: procedural
      complications, incidence of stroke and death. Descriptive statistics will be used for
      baseline, procedure and follow-up data collected through the registry.

      Clinical history of each patient will be analyzed for a period of 6 months after the
      procedure according the standard practice at the enrolling centers. There will be no
      additional visits, nor procedures, for subjects in the registry.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Periprocedural complications</measure>
    <time_frame>At implant</time_frame>
    <description>Pericardial effusion, stroke, device embolization and bleeding</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Stroke</measure>
    <time_frame>6 months follow up</time_frame>
    <description>Stroke</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Death</measure>
    <time_frame>6 months follow up</time_frame>
    <description>Cardiovascular and no cardiovascular death</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Left atrial appendage closure with Watchman device</intervention_name>
    <description>Percutaneous left atrial appendage closure using Watchman device</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial fibrillation and indication for left atrial appendage closure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were eligible for a WatchmanTM device implantation according to current
             international and local guidelines and per physician and institution discretion.

        Exclusion Criteria:

          -  Patient who were currently enrolled in another investigational study or registry that
             would directly interfere with the current study aims.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centro Medico Docente la Trinidad</name>
      <address>
        <city>Caracas</city>
        <state>Miranda</state>
        <zip>1080</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Venezuela</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 24, 2018</study_first_submitted>
  <study_first_submitted_qc>August 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <last_update_submitted>August 27, 2018</last_update_submitted>
  <last_update_submitted_qc>August 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Medico Docente la Trinidad</investigator_affiliation>
    <investigator_full_name>Luis Cressa</investigator_full_name>
    <investigator_title>Interventional Cardiologist</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Left atrial appendage</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

